Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.70 (-2.78%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £34.70m
LINV Live PriceLast checked at - London Stock Exchange

Intraday Lendinvest Share Chart

LENDINVEST 8.25% NOTES 2030: OFFER CLOSING EARLY

11 Nov 2025 10:01

RNS Number : 0570H
Lendinvest PLC
11 November 2025
 

This is an advertisement and not a prospectus.

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the European Economic Area or in any other jurisdiction where it is unlawful to distribute this document.

UK MiFIR retail investors, professional investors and ECPs target market - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients (all distribution channels) and also retail clients (all distribution channels).

 

LENDINVEST SECURED INCOME III PLC 8.25% NOTES DUE 2030

Early Closure of Offer Period

LendInvest Secured Income III plc (the "Issuer") announces that the Offer Period for the LendInvest Secured Income III plc 8.25% Notes due 2030 (the "Notes") will close at 12pm (London time) on 11 November 2025, such time and date being earlier than the originally scheduled end to the Offer Period which was 4.00 pm (London time) on 11 November 2025.

The results of the offer will be specified in the Announcement of Results and Final Terms Confirmation, which is expected to be made on or around 12 November 2025.

Defined terms used herein shall have the meanings attributed to them in the Final Terms dated 14 October 2025 in relation to the Notes.

-ENDS-

 

For further information, please contact:

LendInvest  

Hugo Davies, Chief Capital Officer & Managing Director LI Mortgages

Frederick Newman, Director of Treasury MarketsChris Semple, Head of Corporate Communications & Investor Relations

Email: investorrelations@lendinvest.com 

Telephone:

+44 (0)20 3747 4187

Allia C&C Ltd

Mark Glowrey

Telephone:

+44 (0)20 3039 3465

 

This announcement is an advertisement within the meaning of Article 2(k) of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the "UK Prospectus Regulation") and is not a prospectus for the purposes of the UK Prospectus Regulation. A Base Prospectus dated 13 October 2025 (the "Base Prospectus") and Final Terms dated 14 October 2025 relating to the Notes have been prepared and made available to the public in accordance with the UK Prospectus Regulation. The Base Prospectus and Final Terms are available on the website of LendInvest plc (https://www.lendinvest.com/capital/listed-bond-5).

The Base Prospectus has been approved by the Financial Conduct Authority (the "FCA") as competent authority under the UK Prospectus Regulation. The FCA only approves the Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the UK Prospectus Regulation. Such approval should not be considered as an endorsement of LendInvest plc, LendInvest Secured Income III plc or the quality of the Notes that are the subject of the Base Prospectus.

Potential investors should read the Base Prospectus and Final Terms before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the Notes. Investors should not subscribe for any notes referred to in this announcement except on the basis of information in the Base Prospectus and Final Terms.

The restriction on financial promotions contained in section 21(1) of the Financial Services and Markets Act 2000 does not apply to this announcement by virtue of article 70(1A) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended.

The offering and the distribution of this announcement and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any Notes. Any purchase of Notes pursuant to the offer should only be made on the basis of the information contained in the Base Prospectus and Final Terms.

The Notes have not been and will not be registered under the United States Securities Act of 1933 (as amended, the "Securities Act") and, subject to certain exceptions, may not be offered or sold within the United States or to, or for the account or benefit of, United States persons. The Notes are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPPKDBKKBDDKDD
Date   Source Headline
9th Feb 20245:23 pmRNSBlock Listing Six Monthly Return
26th Jan 202410:17 amRNSDirector/PDMR Notification
24th Jan 20247:00 amRNSPDMR dealing
5th Jan 20247:00 amRNSSale of residual economic interest in RMBS
19th Dec 20237:00 amRNSInterim Financial Results
30th Nov 20237:00 amRNSAnnouncement of Securitisation Settlement
22nd Nov 20234:42 pmRNSAnnouncement of Securitisation Transaction
4th Oct 20237:00 amRNSNotification of transactions by PCA with PDMR
28th Sep 202310:54 amRNSPublication of Final Terms
28th Sep 20238:19 amRNSFinal Terms Confirmation
22nd Sep 202310:26 amRNSIssue of shares to EBT and Total Voting Rights
18th Sep 202312:05 pmRNSResults of AGM
13th Sep 20231:23 pmRNSLaunch of 11.5% Bonds due 2026 and Exchange Offer
12th Sep 20231:42 pmRNSPublication of Base Prospectus
8th Sep 20239:57 amRNSConclusion of IT security event
5th Sep 202310:30 amRNSTrading update
4th Sep 202310:00 amRNSRoadshow announcement
25th Aug 20237:00 amRNSNotice of data breach
11th Aug 20238:59 amRNSBlock listing Interim Review
10th Aug 20231:55 pmRNSHolding(s) in Company
10th Aug 20231:47 pmRNSHolding(s) in Company
7th Aug 20234:28 pmRNSHolding(s) in Company
7th Aug 20234:26 pmRNSDirector/PDMR Notification
18th Jul 20237:00 amRNSLendInvest plc Full Year Financial Results FY23
3rd Jul 20237:00 amRNSAnnouncement of £500 million funding partnership
30th May 20237:00 amRNSLendInvest sells Buy-to-Let mortgage portfolio
5th May 202312:07 pmRNSPDMR Exercise of Share Options
5th May 202311:53 amRNSDirectorate Change
19th Apr 20233:22 pmRNSSale of residual economic interest in RMBS
13th Apr 20237:00 amRNSTrading Update
22nd Mar 202311:40 amRNSIssue of Shares to EBT and Total Voting Rights
1st Mar 20234:47 pmRNSSale of residual economic interest in RMBS
13th Feb 20237:00 amRNSBlock Listing Six Monthly Return
3rd Feb 20234:24 pmRNSDirector/PDMR Notification
17th Jan 20237:00 amRNSLendInvest secures funding from Lloyds Bank
19th Dec 20224:18 pmRNSNew £100 million financial partnership
19th Dec 20227:00 amRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Financial Results
14th Oct 202210:41 amRNSDirector/PDMR Shareholding
11th Oct 202210:09 amRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSTrading Update
8th Sep 20224:02 pmRNSResult of AGM
16th Aug 202210:56 amRNSPDMR Exercise of Share Options
12th Aug 20221:29 pmRNSSale of residual economic interest in RMBS
12th Aug 20227:00 amRNSBlock Listing Six Monthly Return
5th Aug 20227:55 amRNSNotice of Annual General Meeting
29th Jul 20223:14 pmRNSHolding(s) in Company
29th Jul 20223:12 pmRNSHolding(s) in Company
12th Jul 202212:38 pmRNSPublication of Base Prospectus
11th Jul 20224:48 pmRNSUpdate on EBT Purchase and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.